D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 78 Citations 24,864 339 World Ranking 1093 National Ranking 575
Medicine D-index 79 Citations 25,049 350 World Ranking 12303 National Ranking 6412

Research.com Recognitions

Awards & Achievements

2014 - Fellow, National Academy of Inventors

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Virus

His main research concerns Immunology, Cytotoxic T cell, Virology, CD8 and Antigen. His work in T cell, Immune system, Viral load, Viral disease and Cellular immunity are all subfields of Immunology research. His Cytotoxic T cell research is multidisciplinary, relying on both T lymphocyte and Effector.

His research in Virology intersects with topics in Epitope and Orthopoxvirus. His work investigates the relationship between Antigen and topics such as Flow cytometry that intersect with problems in Cytokine, Fusion protein, Receptor, Transfection and Cell culture. His Interleukin 21 research incorporates themes from Natural killer T cell, Natural killer cell, Interleukin 12 and IL-2 receptor.

His most cited work include:

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. (1378 citations)
  • Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. (916 citations)
  • HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function (820 citations)

What are the main themes of his work throughout his whole career to date?

Douglas F. Nixon mainly investigates Immunology, Virology, Immune system, Cytotoxic T cell and T cell. Immunology is a component of his CD8, Viral load, Antigen, Interleukin 21 and Natural killer T cell studies. His Interleukin 21 research includes elements of Interleukin 12 and Cell biology.

Douglas F. Nixon has researched Virology in several fields, including Epitope, ELISPOT, T lymphocyte and CTL*. He focuses mostly in the field of Immune system, narrowing it down to matters related to Human leukocyte antigen and, in some cases, Allele. The study incorporates disciplines such as Major histocompatibility complex, Simian immunodeficiency virus and Effector in addition to Cytotoxic T cell.

He most often published in these fields:

  • Immunology (64.00%)
  • Virology (46.00%)
  • Immune system (30.00%)

What were the highlights of his more recent work (between 2017-2021)?

  • Virology (46.00%)
  • Immunology (64.00%)
  • Virus (16.86%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Virology, Immunology, Virus, Cell biology and Immune system. His Virology research is multidisciplinary, incorporating elements of Epitope, Cd4 t cell and Severe acute respiratory syndrome coronavirus 2. His Immunology study frequently draws connections to other fields, such as Gene expression.

His study in Virus is interdisciplinary in nature, drawing from both SNP, Fetus and Downregulation and upregulation, Gene. The concepts of his Immune system study are interwoven with issues in Cancer research, Transcription and Breast cancer. As a part of the same scientific study, he usually deals with the Effector, concentrating on Virus latency and frequently concerns with Cytotoxic T cell.

Between 2017 and 2021, his most popular works were:

  • Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells (87 citations)
  • The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. (76 citations)
  • The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. (76 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Virus

His scientific interests lie mostly in Virology, Cell biology, Virus, CD8 and Zika virus. His Virology research includes themes of Epidemiology, Immune system and Severe acute respiratory syndrome coronavirus 2. His Immune system study combines topics in areas such as Virus latency, Human endogenous retrovirus K, Endogenous retrovirus and Epigenetics.

His Cell biology study deals with Receptor intersecting with T cell, RAR-related orphan receptor gamma, NKG2D, MHC class I and T-cell receptor. The various areas that Douglas F. Nixon examines in his Virus study include Disease reservoir, Viral quasispecies, Human leukocyte antigen, Genotype and CTL*. His studies deal with areas such as Cell, Mucosal associated invariant T cell, Virus Activation, Epitope and Effector as well as CD8.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar.
Science (1998)

1788 Citations

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

R E Phillips;S Rowland-Jones;D F Nixon;F M Gotch.
Nature (1991)

1286 Citations

HIV-Specific Cd8+T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

Victor Appay;Douglas F. Nixon;Sean M. Donahoe;Geraldine M.A. Gillespie.
Journal of Experimental Medicine (2000)

1119 Citations

Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

Jeff E. Mold;Jakob Michaëlsson;Trevor D. Burt;Marcus O. Muench.
Science (2008)

846 Citations

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

R. Brad Jones;Lishomwa C Ndhlovu;Jason D. Barbour;Prameet M. Sheth.
Journal of Experimental Medicine (2008)

827 Citations

Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

Sandra Lopez-Vergès;Jeffrey M. Milush;Brian S. Schwartz;Marcelo J. Pando.
Proceedings of the National Academy of Sciences of the United States of America (2011)

714 Citations

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

Sandra Lopez-Vergès;Jeffrey M. Milush;Suchitra Pandey;Vanessa A. York.
Blood (2010)

682 Citations

Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens

Einar M. Aandahl;Jakob Michaëlsson;Walter J. Moretto;Frederick M. Hecht.
Journal of Virology (2004)

625 Citations

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

Douglas F. Nixon;Alain R. M. Townsend;John G. Elvin;Charles R. Rizza.
Nature (1988)

590 Citations

An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

Nina F. Rose;Preston A. Marx;Preston A. Marx;Amara Luckay;Douglas F. Nixon.
Cell (2001)

562 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Douglas F. Nixon

Bruce D. Walker

Bruce D. Walker

Harvard University

Publications: 299

Philip J. R. Goulder

Philip J. R. Goulder

University of Oxford

Publications: 167

Andrew J. McMichael

Andrew J. McMichael

University of Oxford

Publications: 160

Paul Klenerman

Paul Klenerman

University of Oxford

Publications: 118

Marcus Altfeld

Marcus Altfeld

Heinrich-Pette-Institute

Publications: 117

Sarah Rowland-Jones

Sarah Rowland-Jones

University of Sheffield

Publications: 108

David Price

David Price

University of Aberdeen

Publications: 108

Steven G. Deeks

Steven G. Deeks

University of California, San Francisco

Publications: 105

David C. Montefiori

David C. Montefiori

Duke University

Publications: 82

Norman L. Letvin

Norman L. Letvin

Beth Israel Deaconess Medical Center

Publications: 82

Mary Carrington

Mary Carrington

MIT

Publications: 80

Rodney E. Phillips

Rodney E. Phillips

University of Oxford

Publications: 76

Eric S. Rosenberg

Eric S. Rosenberg

Harvard University

Publications: 71

Karl-Johan Malmberg

Karl-Johan Malmberg

Oslo University Hospital

Publications: 69

Johan K. Sandberg

Johan K. Sandberg

Karolinska University Hospital

Publications: 68

Zabrina L. Brumme

Zabrina L. Brumme

Simon Fraser University

Publications: 66

Trending Scientists

Yongcheol Shin

Yongcheol Shin

University of York

Zhenya Yan

Zhenya Yan

Chinese Academy of Sciences

Julia Kempe

Julia Kempe

New York University

Jamie R. Lead

Jamie R. Lead

University of South Carolina

Chunli Bai

Chunli Bai

Chinese Academy of Sciences

Maurizio Avella

Maurizio Avella

National Research Council (CNR)

James Douglas Engel

James Douglas Engel

University of Michigan–Ann Arbor

Fred Sherman

Fred Sherman

University of Rochester

Sergio Roman-Roman

Sergio Roman-Roman

Institute Curie

Glenda Kohlhagen

Glenda Kohlhagen

National Institutes of Health

Henri A. Verbrugh

Henri A. Verbrugh

Erasmus University Rotterdam

Maria J. Wawer

Maria J. Wawer

Johns Hopkins University

James B. Gill

James B. Gill

University of California, Santa Cruz

Rhodri Ceredig

Rhodri Ceredig

National University of Ireland, Galway

George M. Yousef

George M. Yousef

University of Toronto

Something went wrong. Please try again later.